Skip to main content
. 2009 Dec 1;102(2):276–284. doi: 10.1038/sj.bjc.6605472

Figure 1.

Figure 1

(A) Number of CTCs detected in 7.5 ml of blood taken from healthy controls (N=20) and metastatic breast cancer (MBC) patients (N=76) when samples were analysed with the CellSearch CTC test. (B) Normalised relative gene expression levels of CK-19 detected in blood from MBC patients (N=76) when samples were analysed using a real-time RT-PCR assay. (C) Normalised relative gene expression levels of mammaglobin detected in blood from MBC patients (N=76) when samples were analysed using a real-time RT-PCR assay. Treated: patients with MBC during treatment. Untreated: patients with MBC receiving no treatment.